Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep34 | Adrenal cortex | ECE2015

Selective adrenal venous sampling is not always useful in primary aldosteronism

Paja Miguel , Pena Borja , Calles Laura A , Moreno Cristina

Adrenal venous sampling (AVS) is regarded as the gold-standard for the study of lateralisation of primary aldosteronism (PA) after its biochemical diagnosis. After catheterisation of both adrenal veins, confirmed by ratio of cortisol concentration in each adrenal vein and peripheral vein (selectivity index (SI)), lateralization is accepted if aldosterone/cortisol (A/C) ratio between both adrenal veins is over 3–4 (lateralization index (LI)), particularly if non-dominant v...

ea0041gp98 | Diabetes (2) | ECE2016

Efficacy and safety of SGLT2 inhibitor Canagliflozin in the treatment of type 2 diabetes mellitus in clinical practice

Martin-Timon Iciar , Sevillano-Collantes Cristina , Moreno-Ruiz Inmaculada , Javier del Canizo-Gomez Francisco

In clinical trials, the SGLT2 inhibitor Canagliflozin inhibits renal reabsorption of glucose, increases its excretion and reduces hyperglycaemia in patients with type 2 diabetes mellitus (T2DM). The increase in glucosuria and diuresis produced, results in a reduction in weight and blood pressure (BP). Moreover, It may cause genital and urinary tract infections. However, does Canagliflozin behave in the same way in routine clinical practice?Objective: To ...

ea0041ep55 | Adrenal cortex (to include Cushing's) | ECE2016

Outcome with surgical treatment in subclinical hypercortisolism

Moreno Cristina , Paja Miguel , Zabalegui Alba , Dublang Maddalen , Etxeberria Eider , Oleaga Amelia , Teresa Gutierrez M

Introduction: Subclinical hypercortisolism (SH), a condition of biochemical cortisol excess without the classical signs or symptoms of overt hypercortisolism, is thought to be present in the 5–30% of patients with incidentally discovered adrenal mass (adrenal incidentalomas). Some evidence suggest that this condition may lead to long-term consequences of cortisol excess, but indication and potential benefits of adrenalectomy in this state are still in doubt. We analyse a ...

ea0032p538 | Endocrine tumours and neoplasia | ECE2013

Incidental thyroid carcinomas in patients operated on for benign thyroid pathology, are there preoperative factors suggesting a higher risk?

Paja Miguel , Ugalde Aitziber , Barrios Borja , Oleaga Ameli , Calles Laura , Moreno Cristina , Ugarte Estibaliz , Oleaga Amelia

Introduction: The discovery of incidental thyroid carcinomas (ITC) in patients undergoing surgery for a benign disease range between 3 and 16% of cases. During years, patients with hyperthyroidism were considered protected by TSH suppression (TSH is well known factor that favors the development of thyroid cancer). Thyroid size might be a predictive factor due to the excess of thyroid tissue prone to mutations. The knowledge of determining factors foretelling the presence of un...

ea0022p240 | Clinical case reports and clinical practice | ECE2010

Synergic effect of Cabergoline in acromegaly treated with somatostatin analogues. Report of two cases

Paja Miguel , Perez-Yeboles Josu , Lizarraga Aitzol , Moreno Cristina , Isusquiza Ana , Elorza J Ramon

Current treatment for acromegaly includes dopamine agonists (DA), somatostatin receptor ligands (SRL) and GH receptor antagonists (GHRA). DA in monotherapy, is less than 10% effective achieving control of the disease, and its efficacy in addition to ongoing SRL is less studied, without obvious determining factors of response. We report 2 operated patients with incomplete response to SRL and to whom Cabergoline addition led to disease control.Case 1: A ma...

ea0022p838 | Thyroid | ECE2010

Simultaneous thyroid and gastric autoimmune disease: clinical aspects of 78 cases

Paja Miguel , Lizarraga Aitzol , Moreno Cristina , Ugarte Estibaliz , Perez-Yeboles Josu , Oleaga Amelia

Autoimmune polyendocrinopathy syndromes (APS) gather a wide range of diseases. The association of autoimmune thyroid disease (ATD) with other organ specific diseases is frequent. Atrophic body gastritis (ABP) is characterized by the loss of ClH and intrinsic factor (IF) production. Both ATD and ABP are known to be associated since 1960 but there are scarce publications describing its clinical features.We review patients with this association selected fro...

ea0016p808 | Thyroid | ECE2008

Is pre-ablative thyroglobulin useful as a predictor of cure in differentiated thyroid carcinoma?

Paja Miguel , Oleaga Amelia , Perez Josu , Lizarraga Aitzol , Moreno Cristina , Izuzquiza Ana , Goni Fernando

Surgery followed by 131I ablative therapy (IAT) is the usual treatment for patients with differentiated thyroid carcinoma (DTC). Thyroglobulin levels obtained 9–12 months after IAT under TSH stimulation (Tg2) is a very reliable marker for the presence of thyroid tissue. The value of stimulated thyroglobulin previous to ablation (Tg1) is more controversial. The aim of this study was to examine the relationship between Tg1 and Tg2.Material ...

ea0081p402 | Pituitary and Neuroendocrinology | ECE2022

Central pontine myelinolysis: Case report

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , Montalban Mendez Cristina , Moreno Tirado Antonio , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro

Introduction: Central pontine myelinolysis (CPM) is a rare and potentially life-threatening complication of a sudden rise in serum osmolality. Along with extrapontine myelinolysis, it is part of the osmotic demyelination syndrome (ODS). Known risk factors include severe hyponatremia, alcoholism, thiazide use, hypokalemia, and malnourishment.Case report: We report the case of a 31-year-old-male with history of alcohol and cannabis dependence, who had atte...

ea0090p617 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Case Report: Atypical presentation of central pontine myelinolysis in hyperglycemia

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , Moreno Tirado Antonio , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro , Gomez Garcia Ines

Central pontine myelinolysis (CPM) is a neurological disorder typically caused by rapid correction of severe chronic hyponatremia. Conditions causing a hyperosmolar state can also cause CPM, but it is rarely seen in diabetes. We report the case of a 33-year-old woman with personal history of Type 1 Diabetes since she was 9 years old with very poor metabolic control (A1hbC 15%) and microvascular complications, who attended the emergency department due to left hemicranial headac...

ea0049ep112 | Clinical case reports - Pituitary/Adrenal | ECE2017

Paraganglioma (PG) and cyanotic congenital heart disease (CCHD): the role of tisular hypoxia

Oleaga Amelia , Goni Fernando , Paja Miguel , Ugarte Estibaliz , Moreno Cristina , Iglesias Natalia , Etxeberria Eider , Calles Laura , Dublang Maddalen , Zabalegui Alba

Introduction: CCHD comprises a number of different congenital heart defects associated with elevated pulmonary artery pressure and pulmonary vascular resistance, resulting in a reversed or bidirectional shunt (Eisenmenger syndrome). These entities develop systemic hypoxia. Pheochromocytoma and paraganglioma (PHEO/PG) are neuroendocrine tumours. Several inheritance genetic alterations have been reported in PHEO/PG syndromes. A pathogenic association between these entities is pr...